bg-img9.jpg
8.jpg

Select Author

Validating the Stability and Durability of Labels After Thawing from Cryogenic Temperatures

Working at cryogenic temperatures presents many challenges. One important element involves ensuring labels remain intact and securely adhered to packaging after application as product moves from ambient temperatures to cryogenic temperatures to thawing at the point of use.

Topic: Biobanking and Biorepository, Topic: Cell T..........

Determining Optimum Maintenance Temperature for Advanced Therapies, Part 2

As discussed in my previous blog, there are many factors that need to be considered when selecting an effective maintenance temperature. Those factors include volume, handling processes, storage, and equipment. In part two of this blog series, I will focus on the impact that some of these variables can have on determining an optimum maintenance temperature for advanced therapies.

Topic: Biobanking and Biorepository, Topic: Cold-C..........

Phacilitate Cell and Gene Therapy World 2018: Translating innovation to global success

As the past year has proven, the advancements in cell and gene therapy are increasing at a rapid pace and are transforming the way we think about medicine. Whether in research or in the clinic, scientific innovators are acutely aware that every moment counts when working with these valuable therapies. To facilitate knowledge sharing and collaboration, Thermo Fisher Scientific is proud to support Phacilitate Cell and Gene Therapy World 2018 as the Platinum Sponsor. 

Topic: Cold-Chain Logistics, Topic: Cell Therapy S..........

Case Studies in Supply Chain Management: Getting it Right From the Start Part 2, Planning for Allogeneic Therapies

As discussed in my previous blog post, consistent management and communication are the keys to success when managing the supply chain of any advanced therapy clinical trial.  It is important to remember that each part of the supply chain is equally critical and requires careful management and strategic planning.

Topic: Cold-Chain Logistics, Topic: Qualification ..........

Fisher BioServices Top Five Most Popular Blogs of 2017

2017 has been a year filled with new discoveries in the health and medical R&D space. Through our blog, we have shared great stories of our customers' work and discussed a wide-breadth of topics, focusing on advanced therapies, biological material, and public health research.

Topic: Biobanking and Biorepository, Topic: Cold-C..........

Case Studies in Supply Chain Management: Getting it Right From the Start Part 1, Planning for Autologous Therapies

Consistent management and communication are the keys to success when managing the supply chain of any advanced therapy clinical trial. In this two part blog series I’ll review two case studies that demonstrate the importance of supply chain management by focusing on scaling up for commercial distribution and on packaging challenges within a cryogenic environment.

Topic: Cold-Chain Logistics, Topic: Qualification ..........

Determining Optimum Maintenance Temperature for Advanced Therapies, Part 1

As referenced in a previous blog post, understanding the proper method of safely cryopreserving your material is essential, but of equal importance is determining the optimum maintenance temperature. There are many factors that need to be considered when selecting an effective maintenance temperature. Those factors include volume, handling processes, storage and handling equipment and the impact of multiple short duration exposures. In this two part blog series, we’ll discuss four areas that need to be understood to determine the optimum maintenance temperature for advanced therapy material.

Topic: Biobanking and Biorepository, Topic: Cold-C..........

24 Hours of Stem Cells

Stem cell research is one of the fastest growing areas in science. This is largely due to its immense potential to impact the future of medicine and how we treat diseases. Whether in basic research or advanced therapy applications, Fisher BioServices is committed to the expansion of this field. To facilitate knowledge sharing and collaboration, Thermo Fisher Scientific is hosting the 5th Annual 24 Hours of Stem Cells event - the day the world revolves around stem cells.

Topic: Cell Therapy Solutions, Content: Blog

Scaling the Advanced Therapy Supply Chain

Treating castration resistant prostate cancer means that failure within the advanced therapy supply chain has a catastrophic impact on patients.

Topic: Cold-Chain Logistics, Topic: Cell Therapy S..........

Cell & Gene Meeting on the Mesa 2017

The advancements in advanced therapy are increasing at a rapid pace and are transforming the way we think about medicine. Whether in research or in the clinic, scientific innovators are acutely aware that every moment counts when working with these valuable therapies. To facilitate knowledge sharing and collaboration, we are pleased to announce our participation as a gold sponsor at the Cell & Gene Meeting on the Mesa in La Jolla, California.

Topic: Cell Therapy Solutions, Content: Blog

Optimizing Advanced Therapy Supply Chain Design to Ensure Commercial Success

The advanced therapy supply chain is complex and made up of multiple moving parts. With milestone achievements such as the recent FDA approval of Novartis' CAR-T cell therapy Kymriah™ it's essential that we address the challenges of delivering these ground breaking therapies to patients on a global scale.

Topic: Cold-Chain Logistics, Content: Webinar, Top..........

Controlling Complexity [Not Cost] of Advanced Therapy Supply Chain

Due to the short shelf life and clinical criticality of advanced therapies, their supply chains are often highly complex.  Once efficacy and safety is demonstrated, the focus of advanced therapy developers moves to controlling cost.  However, the biggest cost within the supply chain is caused by its complexity.  In this blog we will share why the advanced therapy supply chain is so complex and how this complexity correlates to cost.

Topic: Cell Therapy Solutions, Content: Blog